Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents

BACKGROUND: Because limited data are available, the present study investigated 2-year major clinical outcomes after angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs) therapy in patients with acute myocardial infarction (AMI) and prediabetes after suc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yong Hoon, Her, Ae-Young, Jeong, Myung Ho, Kim, Byeong-Keuk, Hong, Sung-Jin, Park, Sang-Ho, Kim, Seunghwan, Ahn, Chul-Min, Kim, Jung-Sun, Ko, Young-Guk, Choi, Donghoon, Hong, Myeong-Ki, Jang, Yangsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Via Medica 2023
Materias:
Clinical Cardiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508070/
https://www.ncbi.nlm.nih.gov/pubmed/34622435
http://dx.doi.org/10.5603/CJ.a2021.0116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10508070/
https://www.ncbi.nlm.nih.gov/pubmed/34622435
http://dx.doi.org/10.5603/CJ.a2021.0116

Ejemplares similares